Exhibitors 2023



AI per la diagnosi precoce dei tumori ginecologici

AI per la diagnosi precoce dei tumori ginecologici

SynDiag is a Fem Tech and Med Tech startup, founded in 2019 as a spin off company of the Polytechnic University of Turin. SynDiag has developed OvAi to allow the early diagnosis of ovarian cancer, the deadliest cancer among women cancers due to late diagnosis. OvAi is a Software as a Medical Device, CE marked, based on Artificial Intelligence for both objective reading of ultrasound exams and for virtual biopsy of detected ovarian tumors. OvAi can be adopted during any visits and acts as an expert colleague, always available to provide an explainable second opinion on diagnostic decisions.

AI per la diagnosi precoce dei tumori ginecologici

SynDiag

SynDiag is a Fem Tech and Med Tech company, born in Turin - Italy - in 2019 with the aim of leading the Digital Transformation in Gynecology and medical ultrasound. SynDiag is an innovative High Technology startup, spin off of the Polytechnic of Turin, founded by three experts in Artificial Intelligence, Daniele Conti, PhD - CEO, Rosilari Bellacosa Marotti, PhD - CTO, Federica Gerace, PhD - AI and R&D Director.


  H5 (pav. 3H.05)
Back
 
Data updated on 2024-07-20 - 8.42.13 pm